Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2021

View Archived Issues

RTX-N109D, a rituximab variant with lower sensitivity to CA125 mediated immunosuppression

SRI-42127 attenuates glial activation in a model of LPS-induced neuroinflammation

Gfap-targeted ASO therapy shows efficacy in rat model of Alexander disease

EIDD-2749 shows broad antiviral activity against RSV, SARS-CoV-2 and related RNA viruses

ED to AD: Viagra associated with lower risk of Alzheimer's disease

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

New ACSS2 inhibitors discovered at Metabomed

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Incyte describes new mutant GTPase KRAS inhibitors

Phylex develops SARS-CoV-2 vaccine targeting Delta and Omicron variants

Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant

Gb Sciences develops cannabinoid-containing complex mixtures to target CRS in COVID-19

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Spago completes regulatory preclinical program with Tumorad

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Bsense reports preclinical data on BSEN-627 in rat pain model

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...